BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27661110)

  • 1. Relationship between tumour PTEN/Akt/COX-2 expression, inflammatory response and survival in patients with colorectal cancer.
    Roseweir AK; Powell AG; Bennett L; Van Wyk HC; Park J; McMillan DC; Horgan PG; Edwards J
    Oncotarget; 2016 Oct; 7(43):70601-70612. PubMed ID: 27661110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of COX-2 and 5-LOX regulates the progression of colorectal cancer by promoting PTEN and suppressing PI3K/AKT pathway.
    Chang J; Tang N; Fang Q; Zhu K; Liu L; Xiong X; Zhu Z; Zhang B; Zhang M; Tao J
    Biochem Biophys Res Commun; 2019 Sep; 517(1):1-7. PubMed ID: 29339153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?
    Colakoglu T; Yildirim S; Kayaselcuk F; Nursal TZ; Ezer A; Noyan T; Karakayali H; Haberal M
    Am J Surg; 2008 Jun; 195(6):719-25. PubMed ID: 18440486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-92a Promotes Cell Metastasis of Colorectal Cancer Through PTEN-Mediated PI3K/AKT Pathway.
    Ke TW; Wei PL; Yeh KT; Chen WT; Cheng YW
    Ann Surg Oncol; 2015 Aug; 22(8):2649-55. PubMed ID: 25515201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and mechanism of microRNA-181A on incidence and survival in late liver metastases of colorectal cancer.
    Li Z; Wang H; Xu Z; Sun Y; Han J
    Oncol Rep; 2016 Mar; 35(3):1403-8. PubMed ID: 26750720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
    Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
    Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutively expressed COX-2 in osteoblasts positively regulates Akt signal transduction via suppression of PTEN activity.
    Li CJ; Chang JK; Wang GJ; Ho ML
    Bone; 2011 Feb; 48(2):286-97. PubMed ID: 20854947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post-surgery.
    Breen KJ; O'Neill A; Murphy L; Fan Y; Boyce S; Fitzgerald N; Dorris E; Brady L; Finn SP; Hayes BD; Treacy A; Barrett C; Aziz MA; Kay EW; Fitzpatrick JM; Watson RWG
    Prostate; 2017 Sep; 77(12):1288-1300. PubMed ID: 28726241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Src family kinases, HCK and FGR, associate with local inflammation and tumour progression in colorectal cancer.
    Roseweir AK; Powell AGMT; Horstman SL; Inthagard J; Park JH; McMillan DC; Horgan PG; Edwards J
    Cell Signal; 2019 Apr; 56():15-22. PubMed ID: 30684564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of PTEN on the proliferation and apoptosis of colorectal cancer cells via the phosphoinositol-3-kinase/Akt pathway.
    Sun Y; Tian H; Wang L
    Oncol Rep; 2015 Apr; 33(4):1828-36. PubMed ID: 25683168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer.
    Zheng L; Zhang Y; Liu Y; Zhou M; Lu Y; Yuan L; Zhang C; Hong M; Wang S; Li X
    J Transl Med; 2015 Aug; 13():252. PubMed ID: 26238857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer.
    Kim JG; Chae YS; Sohn SK; Kang BW; Moon JH; Lee SJ; Jeon SW; Park JS; Park JY; Choi GS
    Oncology; 2010; 79(3-4):278-82. PubMed ID: 21412012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma.
    Capodanno A; Camerini A; Orlandini C; Baldini E; Resta ML; Bevilacqua G; Collecchi P
    Hum Pathol; 2009 Oct; 40(10):1408-17. PubMed ID: 19428048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadmium selectively induces MIP-2 and COX-2 through PTEN-mediated Akt activation in RAW264.7 cells.
    Huang YY; Xia MZ; Wang H; Liu XJ; Hu YF; Chen YH; Zhang C; Xu DX
    Toxicol Sci; 2014 Apr; 138(2):310-21. PubMed ID: 24449419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.
    Panigrahi AR; Pinder SE; Chan SY; Paish EC; Robertson JF; Ellis IO
    J Pathol; 2004 Sep; 204(1):93-100. PubMed ID: 15307142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN Overexpression Cooperates With Lithium to Reduce the Malignancy and to Increase Cell Death by Apoptosis via PI3K/Akt Suppression in Colorectal Cancer Cells.
    de Araujo WM; Robbs BK; Bastos LG; de Souza WF; Vidal FC; Viola JP; Morgado-Diaz JA
    J Cell Biochem; 2016 Feb; 117(2):458-69. PubMed ID: 26224641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
    St-Germain ME; Gagnon V; Parent S; Asselin E
    Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
    Xiong B; Cheng Y; Ma L; Zhang C
    Int J Oncol; 2013 Jan; 42(1):219-28. PubMed ID: 23174819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN and p27Kip1 are not downregulated in the majority of renal cell carcinomas--implications for Akt activation.
    Hennenlotter J; Ohneseit PA; Simon P; Merseburger AS; Serth J; Kuehs U; Kramer M; Hartmann JT; Stenzl A; Kuczyk MA
    Oncol Rep; 2008 May; 19(5):1141-7. PubMed ID: 18425369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.